Zhao-Jun Wang Selected Research

Zhao-Jun Wang Research Topics

Disease

17	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 03/2015
9	Cognitive Dysfunction 04/2024 - 01/2020
4	Memory Disorders (Memory Loss) 04/2023 - 01/2016
4	Type 2 Diabetes Mellitus (MODY) 04/2017 - 06/2016
3	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2023 - 01/2017
3	Osteoarthritis 01/2019 - 10/2016
2	Epilepsy (Aura) 03/2024 - 01/2022
2	Amyloid Plaque 10/2018 - 01/2018
1	Zoonoses 04/2024
1	Glucose Metabolism Disorders 12/2023
1	Vascular Remodeling 05/2023
1	Circadian Rhythm Sleep Disorders (Delayed Sleep Phase Syndrome) 04/2023
1	Anxiety Disorders (Anxiety Disorder) 04/2023
1	Atrial Fibrillation 01/2023
1	Hepatolenticular Degeneration (Wilson's Disease) 08/2022
1	ST Elevation Myocardial Infarction 01/2022
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Clonorchiasis 01/2022
1	Digestive System Diseases 01/2022
1	Glioma (Gliomas) 01/2022
1	Infections 01/2022
1	COVID-19 01/2022
1	Neoplasms (Cancer) 01/2022
1	Seizures (Absence Seizure) 01/2022
1	Wounds and Injuries (Trauma) 01/2020
1	Chronobiology Disorders (Circadian Rhythm Disorder) 01/2020
1	Iron Deficiencies 09/2019
1	Iron Overload 09/2019
1	Parkinson Disease (Parkinson's Disease) 10/2018
1	Neuroinflammatory Diseases 01/2018
1	Cardiomyopathies (Cardiomyopathy) 09/2017
1	Hemorrhage 01/2017

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 09/2022 - 01/2006
10	Amyloid (Amyloid Fibrils)IBA 04/2024 - 03/2015
4	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2023 - 01/2017
3	OrexinsIBA 04/2024 - 01/2020
3	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 03/2024 - 01/2022
3	Advanced Glycation End ProductsIBA 01/2019 - 10/2016
2	Orexin ReceptorsIBA 04/2024 - 01/2023
2	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 06/2016
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2006
2	Peptides (Polypeptides)IBA 10/2018 - 03/2015
2	Insulin (Novolin)FDA Link 01/2017 - 06/2016
1	hydroxide ionIBA 04/2024
1	Sirtuin 1IBA 12/2023
1	semaglutideIBA 12/2023
1	Ketone BodiesIBA 10/2023
1	Competitive Endogenous RNAIBA 08/2023
1	Long Noncoding RNAIBA 08/2023
1	Melatonin Receptors (Melatonin Receptor)IBA 04/2023
1	Serotonin (5 Hydroxytryptamine)IBA 04/2023
1	Dopamine (Intropin)FDA LinkGeneric 04/2023
1	agomelatine (S20098)IBA 04/2023
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 04/2023
1	1- (2- methylbenzoxazol- 6- yl)- 3- (1,5)naphthyridin- 4- yl ureaIBA 01/2023
1	AntralIBA 01/2023
1	OxyntomodulinIBA 09/2022
1	Amyloid beta-PeptidesIBA 09/2022
1	Penicillamine (Cuprimine)FDA Link 08/2022
1	CytokinesIBA 01/2022
1	ferric chlorideIBA 01/2022
1	EnzymesIBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	Immunoglobulin E (IgE)IBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Oxidoreductases (Dehydrogenase)IBA 01/2022
1	ferrostatin-1IBA 01/2022
1	trichostatin A (A 300)IBA 01/2021
1	AlbuminsIBA 01/2021
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	SynaptophysinIBA 01/2021
1	TensinsIBA 01/2021
1	Calcium Release Activated Calcium ChannelsIBA 01/2020
1	suvorexantIBA 01/2020
1	cadherin 5IBA 01/2020
1	Orexin Receptor AntagonistsIBA 01/2020
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2020
1	Actins (F Actin)IBA 01/2020
1	Cysteine (L-Cysteine)FDA Link 01/2020
1	Ferritins (Ferritin)IBA 09/2019
1	Inositol 1,4,5-Trisphosphate Receptors (Inositol Triphosphate Receptor)IBA 01/2019
1	xestospongin CIBA 01/2019
1	SynucleinsIBA 10/2018
1	lixisenatideIBA 01/2018
1	Neuroprotective AgentsIBA 04/2017
1	davunetideIBA 01/2017
1	CJC 1131IBA 01/2017
1	Lidocaine (Xylocaine)FDA LinkGeneric 01/2017
1	Local AnestheticsIBA 01/2017
1	Hypoglycemic Agents (Hypoglycemics)IBA 06/2016
1	TeaIBA 04/2015
1	AntioxidantsIBA 04/2015

Therapy/Procedure

1	Oral Administration 04/2024
1	Therapeutics 05/2023
1	Catheter Ablation 01/2023
1	Drug Therapy (Chemotherapy) 01/2022
1	Percutaneous Coronary Intervention 01/2022
1	Immunotherapy 01/2022
1	Cardiac Resynchronization Therapy 09/2017